VBP15 inhibits NFκB activity.
- Jesse M. Damsker (410730)
- Blythe C. Dillingham (410731)
- Mary C. Rose (410732)
- Molly A. Balsley (410733)
- Christopher R. Heier (410734)
- Alan M. Watson (410735)
- Erik J. Stemmy (410736)
- Roslyn A. Jurjus (410737)
- Tony Huynh (410738)
- Kathleen Tatem (410739)
- Kitipong Uaesoontrachoon (410740)
- Dana M. Berry (410741)
- Angela S. Benton (314055)
- Robert J. Freishtat (314056)
- Eric P. Hoffman (165077)
- John M. McCall (410742)
- Heather Gordish-Dressman (54143)
- Stephanie L. Constant (317851)
- Erica K. M. Reeves (410743)
- Kanneboyina Nagaraju (241056)
Publication date
May 2013
DOIAbstract
<p>A549 cells stably-transfected with a luciferase NFκB construct were exposed to increasing concentrations of VBP15 or prednisolone (3, 30, 300, 3000 nM) followed by TNFα stimulation before measuring luciferase activity. Bar graph represents mean (±SE) luciferase units. *<i>p</i><.012 (due to the Bonferroni adjustment for multiple comparisons) compared to treatment with vehicle control. Data represents 4 biological replicates with assay performed in triplicate.</p
Add to ORKG